Difficulty: Medium
Average Score: 86%
Practice
The following causes of short stature respond to growth hormone:
Correct answer
A
Rationale
In the context of pediatric pharmacology, understanding the role of growth hormone in various conditions affecting growth is crucial. In this question, the correct answer is A) Turner's syndrome. Turner's syndrome is a genetic condition where individuals are missing part or all of one of the X chromosomes, leading to short stature among other physical characteristics. Treatment with growth hormone has been shown to be effective in improving growth in individuals with Turner's syndrome.
Option B) Panhypopituitarism is incorrect because it is a condition where there is a deficiency of all pituitary hormones, not just growth hormone. While growth hormone replacement therapy may be a part of the treatment for panhypopituitarism, it is not the sole cause of short stature in this condition.
Option C) Achondroplasia is a genetic disorder that results in dwarfism and is caused by a mutation in the FGFR3 gene. Growth hormone therapy is not effective in increasing the height of individuals with achondroplasia because the underlying cause of short stature is due to bone growth abnormalities, not growth hormone deficiency.
Option D) Social deprivation is incorrect as it is not a physiological cause of short stature. Social factors can impact a child's overall growth and development, but growth hormone therapy would not be indicated in cases of short stature caused by social deprivation.
Educationally, this question highlights the importance of understanding the specific etiologies of short stature in pediatric patients and how different conditions may or may not respond to growth hormone therapy. It emphasizes the need for precise diagnosis and tailored treatment plans based on the underlying cause of short stature in each individual patient.
Option B) Panhypopituitarism is incorrect because it is a condition where there is a deficiency of all pituitary hormones, not just growth hormone. While growth hormone replacement therapy may be a part of the treatment for panhypopituitarism, it is not the sole cause of short stature in this condition.
Option C) Achondroplasia is a genetic disorder that results in dwarfism and is caused by a mutation in the FGFR3 gene. Growth hormone therapy is not effective in increasing the height of individuals with achondroplasia because the underlying cause of short stature is due to bone growth abnormalities, not growth hormone deficiency.
Option D) Social deprivation is incorrect as it is not a physiological cause of short stature. Social factors can impact a child's overall growth and development, but growth hormone therapy would not be indicated in cases of short stature caused by social deprivation.
Educationally, this question highlights the importance of understanding the specific etiologies of short stature in pediatric patients and how different conditions may or may not respond to growth hormone therapy. It emphasizes the need for precise diagnosis and tailored treatment plans based on the underlying cause of short stature in each individual patient.